-+ 0.00%
-+ 0.00%
-+ 0.00%

Nymox Pharma files amended annual report on Form 20-F/A for 2025

PUBT·09/29/2026 21:28:08
Listen to the news
Nymox Pharma files amended annual report on Form 20-F/A for 2025
  • Nymox Pharmaceutical Corporation published a revised annual report for the year ended Dec. 31, 2025.
  • The filing corrected the date of M&K CPAS, PLLC’s independent audit report to Sept. 11, 2026.
  • No other changes were made to the annual report beyond updated signature, certification, and exhibit items.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nymox Pharmaceutical Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-26-001603), on September 29, 2026, and is solely responsible for the information contained therein.